Physician profile
Jeffrey A Dodge
NPI 1114993482
$1,132.27
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $462 · 2020: $84.30 · 2021: $165 · 2022: $189 · 2023: $200 · 2024: $32.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $232.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $270.73 | 2019-2022 | |
| Hologic Sales and Service, LLC | $135.14 | 2019-2024 | Novasure, Coolseal Generator, Acessa Provu System |
| Exeltis, USA INC. | $135.13 | 2021-2023 | Slynd |
| Astellas Pharma US INC | $128.92 | 2019-2023 | Veozah |
| Pfizer INC. | $79.58 | 2019-2022 | |
| Amgen INC. | $71.38 | 2019 | |
| Sumitomo Pharma America, INC. | $49.94 | 2023 | Myfembree |
| Caldera Medical, INC | $47.60 | 2022 | |
| Amag Pharmaceuticals, INC. | $40.38 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.33 | 2019-2023 | |
| Ge Healthcare | $26.35 | 2021 | |
| Daiichi Sankyo INC. | $24.39 | 2019-2020 | |
| Myovant Sciences INC. | $23.11 | 2022 | |
| Roche Diagnostics Corporation | $22.65 | 2019 | |
| Coopersurgical, INC. | $19.46 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic INC | $11.88 | 2022 | |
| Smith+Nephew, INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Dodge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.